Zimmer Biomet Holdings (ZBH) EPS (Weighted Average and Diluted) (2009 - 2026)

Zimmer Biomet Holdings' EPS (Weighted Average and Diluted) history runs 18 years deep, the most recent figure standing at $1.22 for Q1 2026.

• In Q1 2026, EPS (Weighted Average and Diluted) rose 34.07% year-over-year to $1.22; the TTM figure through Mar 2026 stood at $3.86 (down 14.41% YoY), while the FY2025 annual figure was $3.55, down 19.86% from the prior year.
• EPS (Weighted Average and Diluted) was $1.22 for Q1 2026 at Zimmer Biomet Holdings, up from $0.71 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $2.0 in Q4 2023 to a low of -$0.62 in Q4 2022.
• Historically, EPS (Weighted Average and Diluted) has averaged $0.89 across 5 years, with a median of $0.92 in 2022.
• The sharpest annual moves came in 2022 and 2023: EPS (Weighted Average and Diluted) tumbled 92.55% in 2022, then jumped 1485.71% in 2023.
• A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.62 in 2022, then soared by 422.58% to $2.0 in 2023, then tumbled by 40.5% to $1.19 in 2024, then tumbled by 40.34% to $0.71 in 2025, then soared by 71.83% to $1.22 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $1.22 (Q1 2026), $0.71 (Q4 2025), and $1.16 (Q3 2025), per Business Quant data.